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Abstract: To expand the potential of pseudopterosins and seco-pseudopterosins isolated 
from the octocoral Pseudopterogorgia elisabethae of San André s and Providencia islands 
(southwest Caribbean Sea), we report the anti-microbial profile against four pathogenic 
microorganisms (Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa 
and Candida albicans) and report a more complete cytotoxic profile against five human 
cells lines (HeLa, PC-3, HCT116, MCF-7 and BJ) for the compounds PsG, PsP, PsQ, PsS, 
PsT, PsU, 3-O-acetyl-PsU, seco-PsJ, seco-PsK and IMNGD. For the cytotoxic profiles, all 
compounds evaluated showed moderate and non-selective activity against both tumor and 
normal  cell  lines,  where  PsQ  and  PsG  were  the  most  active  compounds  (GI50  values 
between 5.8 µM to 12.0 µM). With respect to their anti-microbial activity the compounds 
showed good and selective activity against the Gram-positive bacteria, while they did not 
show activity against the Gram-negative bacterium or yeast. PsU, PsQ, PsS, seco-PsK and 
PsG were the most active compounds (IC50 2.9–4.5 µM) against S. aureus and PsG, PsU 
and seco-PsK showed good activity (IC50 3.1–3.8 µM) against E. faecalis, comparable to 
the reference drug vancomycin (4.2 µM). 
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1. Introduction 
The  discovery  of  selective  and  potent  therapeutic  activity  of  pseudopterosins  and  
seco-pseudopterosins isolated from the octocoral Pseudopterogorgia elisabethae [1–14] and the high 
degree  of  chemical  variation  among  specimens  collected  at  different  locations  throughout  the 
Caribbean  region  [1,2],  have  motivated  several  authors  to  pursue  this  field  of  study.  Thus  far,  
30 pseudopterosins (PsA-Y, iso-PsE, 2-O-Ac-PsQ, 3-O-Ac-PsQ, 2-O-Ac-PsU and 2-O-Ac-PsQ) [3–11] 
and 11 seco-pseudopterosins (seco-PsA-K) [8–13] have been isolated from specimens collected in the 
Bahamas, Bermuda, the Florida Keys and the Colombian islands of San André s and Providencia.  
The  pseudopterosins  (PsA-D,  PsE,  iso-PsE,  PsM-O,  PsX  and  PsY)  and  seco-pseudopterosins  
(seco-PsA-G) isolated from specimens collected in the North Caribbean Sea (the Bahamas, Bermuda 
and the Florida Keys) have been evaluated as anti-inflammatory, analgesic and antimicrobial agents 
[2–6,8,12]. Among them, PsN, PsA, iso-PsE and PsE were found to be the most potent compounds in 
mouse  ear  anti-inflammatory  assays  [3,4,6,8].  Furthermore  PsA  and  PsE,  appeared  to  prevent 
eicosanoid biosynthesis by inhibition of PLA2, 5-LO and COX, degranulation of leukocytes and the 
consequent liberation of lysosomal enzymes [15,16]. PsA-E, PsK, PsX, PsY and seco-PsA-D showed 
excellent  and  selective  activity  against  the  Gram-positive  bacteria  Streptococcus  pyogenes, 
Staphylococcus aureus, and Enterococcus faecalis [5,12]. Pseudopterosins are also used in several skin 
care products [1,17]. Methopterosin is a simple derivative of PsA and has completed Phase I and II 
clinical trials as a wound healing agent [17–20]. 
Specimens of P. elisabethae collected in the southwest Caribbean Sea, specifically at the Islands of 
San Andres and Providencia (Colombia), have been shown to contain new pseudopterosins (PsP-V,  
2-O-Ac-PsQ,  3-O-Ac-PsQ,  2-O-Ac-PsU  and  2-O-Ac-PsQ,  PsG  and  PsK),  seco-pseudopterosins  
(seco-PsH-K), and an inter-converting mixture of non-glycosylated diterpenes (10-acetoxy-9-hydroxy- 
and  9-acetoxy-10-hydroxy-amphilecta-8,10,12,14-tetraenes  (IMNGD))  [7,9–11].  However,  only  a 
limited number of these compounds has been evaluated for anti-inflammatory [21], anti-tuberculosis, 
anti-viral, anti-malarial and anti-cancer [11] activity. 
In regards to their anti-inflammatory activity, our experiments showed that fractions enriched with 
pseudopterosins (PsG, PsK, PsP, PsQ, PsS, PsT and PsU) and seco-pseudopterosins (seco-PsJ and 
seco-PsK)  were  able  to  inhibit  the  inflammation  in  a  12-O-tetradecanoyl-phorbol-acetate  
(TPA)-induced edema assay, with results comparable to those shown by indomethacin used as the 
control standard [21]. Additionally, in in vitro experiments, PsQ, PsS, PsT, PsU and IMNGD showed 
good activity for the inhibition of MPO release; PsP, PsT and IMNGD inhibit NO release [21] and PsR 
inhibited thromboxane B2 (TXB2) and the superoxide anion (O2
−) [11].  
In other experiments, PsP was evaluated for anti-viral activity (against HSV-1, HSV-2, HVMV and 
VZV),  and  PsQ,  PsR,  PsU, PsV,  seco-PsH  and seco-PsI evaluated as  anti-malaria agents (against 
Plasmodium  falciparum)  and  as  anti-tuberculosis  agents  (against  Mycobacterium  tuberculosis  Mar. Drugs 2011, 9                          
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H37Rv) [11]. There is only one report discussing the cytotoxic activity of PsQ, PsR, PsU, PsV, and  
3-O-acetyl-PsU against MCF-7 (breast cancer), NCI-H460 (non-small-cell lung cancer), and SF-268 
(CNS) cells [11]. These data suggest that some of these pseudopterosins have some cytotoxicity but 
lack potency.  
While  there  has  been  considerable  effort  towards  characterizing  the  biological  activity  of 
pseudopterosins  isolated  from  octocoral  samples  collected  in  the  northern  Caribbean,  much  is 
unknown about the bioactivity of such compounds isolated from octocoral collected from the Islands 
of San André s and Providencia. For this reason, and with a goal of expanding the potential of these 
compounds,  here  we  report  for  the  first  time  the  antimicrobial  profile  against  four  pathogen 
microorganisms (S. aureus, E. faecalis, Pseudomonas aeruginosa and Candida albicans) and report a 
more complete cytotoxic profile against five human cells lines (HeLa, PC-3, HCT116, MCF-7 and BJ) 
for the compounds: PsG, PsP, PsQ, PsS, PsT, PsU, 3-O-acetyl-PsU, seco-PsJ, seco-PsK and IMNGD 
(Figure 1). 
2. Results and Discussion  
In this study, PsG, PsP, PsQ, PsS, PsT, PsU, 3-O-acetyl-PsU, seco-PsJ, seco-PsK and IMNGD were 
isolated (Figure 1) by flash chromatography and HPLC and identified by spectroscopic means. The 
structures of all compounds were previously reported by us [7,10], and preliminary assessment of their 
cytotoxic (Table 1) and antimicrobial (Table 2) properties is presented here. 
2.1. Cytotoxic Activity 
The cytotoxic activity of the pseudopterosins (PsG, PsP, PsQ, PsS, PsT, PsU and 3-O-acetyl-PsU), 
seco-pseudopterosins  (seco-PsJ  and seco-PsK) and  IMNGD against five cell lines: HeLa (cervical 
cancer),  PC-3  (prostate  cancer),  HCT116  (colorectal  cancer),  MCF-7  (breast  cancer)  and  BJ 
(fibroblasts)  was  investigated  using  the  MTT  reduction  colorimetric  assay  [22].  Although  no 
compound  showed  significant  activity,  according  to  the  GI50  cut  off  value  of  10  nM  for  pure 
compounds suggested by Bugelski et al. [23], all compounds evaluated showed moderate to weak 
(GI50 5.8–83.9 µM) and non-selective activity against both tumor and normal cell lines as shown in 
Table 1.  
While none of these compound showed comparable activity to the reference drug staurosporine 
(GI50 13.6–105.6 nM) against the four tumor cell lines, PsQ and PsG were the most active compounds 
(GI50 values between 5.8 µM to 12.0 µM) and IMNGD showed a moderate activity with GI50 values of 
9.7–19.9 µg/mL. These results are comparable with those previously reported by Rodriguez et al. [11], 
who determined the GI50 values for PsQ, PsU and PsV in the NCI-H460-cell line. Results for PsQ 
showed a GI50 between 1.7–5.8 μM. In the same screen, PsU and PsV were generally much less toxic 
(GI50 20–100 μM). For the normal cell line BJ (Table 1), PsS, 3-O-acetyl-PsU, PsP, PsT and seco-PsJ 
did not show a considerable cytotoxic effect (GI50 > 10 µM) while PsQ, PsG, seco-PsK and PsU 
showed a moderate cytotoxic activity (GI50 4.5–9.3 µM). The IMNGD showed a moderate activity 
with GI50 of 8.3 µg/mL.  
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Figure  1.  Chemical  structures  of  pseudopterosins,  seco-pseudopterosins  and  IMNGD 
isolated from P. elisabethae (SW Caribbean Sea).  
 
The selectivity of the cytotoxic activity of the compounds, measured as the differential effect on 
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inhibiting cell growth in both normal and tumor cells. The results showed no selectivity of compounds 
between the lines used, and all compounds induced reduction in cell survival to a similar magnitude in 
all lines.  
Table 1. Cytotoxic effect of diterpenes isolated from P. elisabethae (SW Caribbean) in 
human cancer cell lines (HeLa, PC-3, HCT116, MCF-7) and normal BJ cells. 
Compounds 
GI50 ±  S.E (µ M) 
HeLa  PC-3  HCT116  MCF7  BJ 
PsG  9.22 ±  0.45  8.83 ±  0.54  12.04 ±  0.36  9.42 ±  0.43  7.62 ±  0.38 
PsP  10.31 ±  0.49  13.77 ±  0.58  17.89 ±  0.45  12.58 ±  0.45  10.40 ±  0.42 
PsQ  5.82 ±  0.33  7.81 ±  0.35  7.66 ±  0.27  8.44 ±  0.41  4.47 ±  0.31 
PsS  13.79 ±  0.39  52.05 ±  0.31  33.50 ±  0.33  26.25 ±  0.45  29.14 ±  0.45 
PsT  14.58 ±  0.35  21.99 ±  0.46  24.24 ±  0.42  14.72 ±  0.46  12.94 ±  0.37 
PsU  15.63 ±  0.32  24.81 ±  0.34  23.44 ±  0.40  26.46 ±  0.46  9.35 ±  0.34 
3-O-Ac-PsU  44.61 ±  0.35  26.45 ±  0.31  20.48 ±  0.48  83.93 ±  0.39  62.03 ±  0.45 
seco-PsJ  21.08 ±  0.37  37.21 ±  0.41  31.68 ±  0.32  28.02 ±  0.51  15.00 ±  0.35 
seco-PsK  15.83 ±  0.18  13.57 ±  0.38  13.28 ±  0.27  11.45 ±  0.36  8.28 ±  0.29 
IMNGD
*  11.20 ±  0.15  12.11 ±  0.20  19.90 ±  0.19  9.67 ±  0.15  7.91 ±  0.17 
Staurosporine
**  105.6 ±  0.41  61.82 ±  0.38  45.56 ±  0.45  176.6 ±  0.38  13.56 ±  0.35 
* GI50 (µ g/mL), ** GI50 (nM) 
Preliminary  conclusions  regarding  structure-activity  relationships  can  be  drawn  from  an 
examination of the cytotoxic activity. The position of glycosylation on the terpene skeleton appears to 
affect the inhibitory activity profile as, for example, PsG (glycosylated in C-9 with fucopyranose) is 
more active than PsP (glycosylated in C-10 with fucopyranose). Further, the type of sugar moiety also 
influences the activity as, for example, PsP which is glycosylated with fucopyranose is more active 
than PsT which is glycosylated with arabinopyranose. Likewise, PsQ (C-4' mono-acetylated fucose as 
sugar moiety) is more active than PsU (C-4' mono-acetylated arabinose as sugar moiety) and seco-PsK 
(non-acetylated fucose as sugar moiety) is more active than seco-PsJ (mono-acetylated arabinose as 
sugar moiety). 
2.2. Antimicrobial Activity 
The  antimicrobial  activity  of  the  pseudopterosins,  seco-pseudopterosins  and  IMNGD  was 
investigated  against  one  Gram-negative  bacterium  (P.  aeruginosa),  two  Gram-positive  bacteria  
(S.  aureus  and  E.  faecalis)  and  one  yeast  (C.  albicans),  using  a  microdilution  method  [24].  The 
majority  of  compounds  evaluated  showed  a  good  IC50  (2.9–7.64  µM)  and  all  showed  a  selective 
activity against both Gram-positive bacteria tested (Table 2), while they did not show activity against 
the Gram-negative bacterium or the yeast.  
PsU,  PsQ,  PsS,  seco-PsK,  PsG  were  the  most  active  compounds  (IC50  2.3–4.5  µM)  against 
S. aureus. The IMNGD showed good activity with IC50 of 2.3 µg/mL. For E. faecalis, PsG, PsU and 
seco-PsK showed better activity (Table 2) compared to the reference drug vancomycin (4.2 µM) while, 
seco-PsJ  and  PsT  exhibited  similar  activity.  The  IMNGD  showed  good  activity,  with  an  IC50  of  Mar. Drugs 2011, 9                          
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3.5 µg/mL. These results are comparable with the activity previously reported for PsA-E, PsK, PsX 
and PsY isolated from specimens collected in the north Caribbean Sea [5], which were reported to 
have minimum inhibitory concentration (MIC) values between 4.2 and 8.8 µM. 
The selectivity observed in our study is comparable to that reported by Ata et al., [5] who reported 
that other pseudopterosins (PsA-E, PsK, PsX and PsY) inhibit the growth of Gram-positive bacteria  
(S.  pyogenes,  S.  aureus,and  E.  faecalis),  while  they  were  inactive  against  Gram-negative  bacteria  
(E. coli and P. aeruginosa). This finding can be related to the fact that many Gram-negative bacteria 
are resistant to toxic agents in the environment, due to the barrier of lipopolysaccharides on their outer 
membrane [25].  
Table 2. Antibacterial activity of diterpenes isolated from P. elisabethae (SW Caribbean) 
in two Gram-positive bacteria. 
Compounds 
IC50 ±  S.E (µ M)
 * 
S. aureus  E. faecalis 
PsG  4.48 ±  0.18  3.14 ±  0.22 
PsP  14.91 ±  0.20  37.35 ±  0.29 
PsQ  3.30 ±  0.20  7.38 ±  0.16 
PsS  3.89 ±  0.23  20.20 ±  0.25 
PsT  5.39 ±  0.25  4.38 ±  0.16 
PsU  2.97 ±  0.17  3.19 ±  0.25 
3-O-Ac-PsU   20.23 ±  0.19  7.64 ±  0.16 
seco-PsJ  6.52 ±  0.12  4.08 ±  0.19 
seco-PsK  4.20 ±  0.16  3.82 ±  0.21 
IMNGD
**  2.33 ±  0.09  3.47 ±  0.15 
Penicillin G  1.61 ±  0.08  - 
Vancomycin  -  4.21 ±  0.11 
* All compounds evaluated were inactive against the Gram-negative bacterium P. aeruginosa and the yeast  
C. albicans. **IC50 (µ g/mL). 
Examination of the data in Table 2 suggests the following structure–activity relationships. Firstly, 
PsG  (glycosylated in C-9 with fucopyranose) is more active than PsP (glycosylated  in  C-10  with 
fucopyranose). Secondly, PsT glycosylated with arabinopyranose is more active than PsP, which is 
glycosylated with fucopyranose. Likewise, PsU (mono-acetylated arabinose as sugar moiety) is more 
active than PsQ and PsS (mono-acetylated fucose as sugar moiety). However, this behavior initially 
observed in pseudopterosins (amphilectane skeleton) is not retained when the results are compared 
with seco-psedopterosins (serrulatane skeleton), where, the seco-PsK (glycosylated with fucoyranose) 
showed more activity than seco-PsJ (glycosylated with arabinopyranose). Clearly, additional work is 
required to fully understand the structure–activity relationships for this family of terpenes. 
From  the  above  discussion,  one  can  note  that  the  pseudopterosins,  seco-pseudopterosins  and 
IMNGD  isolated  from  P.  elisabethae  collected  at  the  Islands  of  San  André s  and  Providencia  
(southwest Caribbean Sea) have a similar drug-like potential as the related compounds isolated from 
specimens  collected  in  the  north  Caribbean  Sea  (the  Bahamas,  Bermuda  and  the  Florida  Keys). 
Further, due to their wide applicability in commercial additives, in the cosmetic industry, it might be Mar. Drugs 2011, 9                          
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important to consider P. elisabethae collected in Colombian waters as an alternative source of such 
compounds. As has been shown, the anti-inflammatory, anti-microbial and cytotoxic activity of this 
family of compounds isolated from P. elisabethae collected at different locations at the Caribbean Sea 
are quite similar, regardless of a small number of differences in their structure (type of sugar moiety, 
position of glycosylation and stereochemistry).  
3. Experimental Section  
3.1. Chemicals and Reagents 
The  following  substances  were  purchased  from  Sigma-Aldrich  (St  Louis,  USA):  Dulbecco's 
modified  Eagle's  medium  (DMEM),  3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium  bromide 
(MTT), staurosporine, vancomycin, penicillin G, gentamicin, nystatin, Luria-Bertani Broth (LB) and 
Sabouraud Dextrose broth (SD). Fetal bovine serum (FBS), salts for phosphate buffered saline (PBS) 
solution and organic solvents, were purchased from WRW (PA, USA). 
3.2. Octocoral Collection  
Fragments of individual colonies of P. elisabethae were collected by SCUBA (ca. 20–30 m depth) 
at Providencia and San André s islands (SW Caribbean) and identified by Dr. Monica Puyana. Voucher 
specimens coded as INV CNI 1612–1616, were deposited at the invertebrate collection of Museo de 
Historia  Natural  Marina  Colombiana  (MHNMC)  at  Instituto  de  Investigaciones  Marinas  de  Punta 
Betí n (INVEMAR).  
3.3. Isolation and Structure Elucidation of Compounds from P. elisabethae 
The  dried  colony  fragments  (30  g)  from  each  location  were  extracted  separately  with  a 
dichloromethane-methanol  (1:1)  mixture.  The  resulting  extracts  were  filtered  and  concentrated  by 
rotary  evaporation  to  obtain  a  dark  green  oil.  The  isolation  of  each  compound  was  carried  out 
according to our previously described procedures [7,10] with some modifications. Each extract was 
subjected separately to flash C18 column chromatography and eluted with 500 mL of each solvent 
mixture of decreasing polarity (methanol-water 1:9, fraction F1; methanol-water 1:1, F2; methanol-
water 4:1, F3; methanol 100% F4; ethanol 100% 5, F5; acetone 100%, F6; dichloromethane-methanol 
5:5, F7; and dichloromethane 100%, F8). Checking by LC-MS and TLC, the fractions F4 and F5 from 
the Providencia extract contained a mixture of pseudopterosins and seco-pseudopterosins and F5 from 
the  San  André s  extract  contained  the  interconverting  mixture  of  non-glycosylated  diterpenes 
(IMNGD). Fraction F4 and F5 from Providencia were mixed and subsequently separated by flash 
chromatography using a diol column (150 g) yielding PsG (19.1 mg), PsP (9.6 mg), PsQ (58.1 mg), 
PsS (2.3 mg), PsT (14.5 mg), PsU (46.6 mg), 3-O-Ac-PsU (3.5 mg), seco-PsJ (16.2 mg) and seco-PsK 
(1.2 mg). Final purification of all compounds was performed on HPLC, using a column Gemini C-18 
(5 µm, 10 ×  250 mm) and MeOH-water (9:1) as the mobile phase with a 3.0 mL/min flow rate. The 
isolated compounds were carefully identified by comparison of their spectral data with that shown by 
our previously isolated compounds [7,8]. Purity was confirmed by HPLC and NMR. Mar. Drugs 2011, 9                          
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3.4. Cell Lines 
The cell lines HeLa (cervical cancer), PC-3 (prostate cancer), HCT116 (colorectal cancer), MCF-7 
(breast cancer) and normal human cell line BJ (skin fibroblasts) were used and maintained in DMEM 
with 5% of FBS and gentamicin 50 μg/mL. Cultures were held in 75 cm
2 culture flasks at 37 °C , 5% 
CO2 and 100% relative humidity, changing media at least twice a week. 
3.5. Cytotoxic Assay 
Cells were harvested, counted, and transferred into 96 well plates and incubated for 24 h prior to the 
addition of the test compounds. Test sample solutions (10 µL) at the desired dilutions were added to 
the wells containing the cells and incubated for 48 h. Microtitration colorimetric method of MTT 
reduction was used to determine surviving cells at the end of the treatment period [22]. 
A solution of MTT (0.5 mg/mL) was prepared in PBS and 100 µL of this solution was added to 
each well after the removal of 100 µL of treatment solution. The plates were incubated at 37 °C  for  
4 h. The solution in each well, containing media, unmetabolized MTT, and dead cells, was removed by 
suction and 100 µL of DMSO was added to each well. The DMSO was mixed by pipetting and optical 
density was recorded using a BioTek Synergy HT microplate reader to measure the absorbance at  
570 nm. Percentages of cell survival relative to vehicle control wells (wells containing only cells and 
DMSO) were calculated. 
Stock solutions (5 mg/mL) were prepared by dissolving pure compounds in DMSO and storing at  
4  ° C.  Serial  dilutions  with  culture  media  were  prepared  just  prior  to  addition  to  test  plates.  The 
concentration of DMSO in wells was consistent across dilutions at 0.38% v/v. Staurosporine was used 
as the positive control and vehicle (DMSO + media) as blank. Control and test compounds (PsG, PsP, 
PsQ, PsS, PsT, PsU, 3-O-Ac-PsU, seco-PsJ, seco-PsK and IMNGD) were assayed in duplicate for each 
concentration and replicated for each cell line at concentrations of 5000, 1000, 500, 100, 50, 10, 5 and 
1 nM for staurosporine and 0.1, 0.5, 1.0, 2.5, 5.0, 7.5, 10.0, and 20.0 µg/mL for compounds.  
3.6. Microbial Strains and Culture Media 
Compounds isolated from P. elisabethae were tested against a panel of microorganisms including 
the bacteria Staphylococcus aureus ATCC 375, Enterococcus faecalis ATCC 10741, Pseudomonas 
aeruginosa ATCC 14210 and the yeast Candida albicans ATCC 14035. Bacterial strains were cultured 
in Luria-Bertani Broth (LB) and C. albicans was cultured in Sabouraud dextrose broth (SD), for 18 h 
at 37 °C  and 220 rpm in a humidified incubator. 
3.7. Antimicrobial Assay 
The antimicrobial activity was determined by a microdilution method (IC50) in 96-well microtiter 
plates using LB media for bacteria and SD media for the yeast seeded liquid media [24]. In all cases, a 
pre-inoculated  dilution  was  made  with  fresh  broth.  A  volume  of  180  L  of  each  microorganism 
suspension was inoculated in each well (10
5 cells/mL) and mixed with 20 µL of treatment solutions. 
Stock solutions were prepared by dissolving pure compounds and controls in 20% DMSO and storing 
at 4 ° C. Penicillin G (S. aureus), vancomycin (E. faecalis), gentamicin (P. aeruginosa) and nystatin  Mar. Drugs 2011, 9                          
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(C. albicans) were used as positive controls and vehicle (DMSO + media) as blank. The final DMSO 
concentration used for dissolving the extracts was less than 20%. Controls and test compounds (PsG, 
PsP, PsQ, PsS, PsT, PsU, 3-O-Ac-PsU, seco-PsJ, seco-PsK and IMNGD) were assayed in duplicate for 
each of the following concentrations: 64.0, 32.0, 16.0, 4.0, 1.0, 0.25 and 0.06 µg/mL. 
Microplates were incubated for 24 h at 37 °C  and optical density was recorded using a BioTek 
Synergy HT microplate reader to measure the absorbance at 600 nm. For each experiment, correction 
for background absorbance was made by subtracting the value for OD600 after the compounds were 
added  (time  0  h).  Percentages  of  microorganism  survival  relative  to  vehicle  control  wells  (wells 
containing  only  microorganism  and  DMSO)  were  calculated.  The  IC50  of  the  controls  were  also 
determined in parallel experiments in order to control for the sensitivity of the standard test organisms. 
3.8. Statistical Analysis 
Data  were  normalized  and  analyzed  using  non-linear  regression  to  elucidate  IC50  values  from 
sigmoidal  dose-response  curves.  Comparison  between  cell  lines  and  microorganisms  used  extra  
sum-of-squares F test to evaluate IC50 between data sets. P < 0.05 was considered as indicative of 
significance using GraphPad Software, Prism V. 5.0. 
4. Conclusions 
All  results  presented  here  contribute  to  the  demonstration  that  the  compounds  isolated  from  
P. elisabethae (SW Caribbean) are promising molecules with potentially useful antimicrobial activity 
profiles. This confirms that this marine organism has great value as a source of lead compounds with 
pharmaceutical applications. Specifically, PsU, PsQ, PsS, seco-PsK and PsG are the most promising 
anti-bacterial  agents.  For  this  reason,  it  will  be  interesting  to  continue  with  molecular  targeted  
high-throughput screens in order to understand their mechanism of action. 
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